Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus

Osteoarthritis (OA) and type 2 diabetes mellitus (T2DM) often coexist due to shared risk factors and high prevalence, but effective treatment methods are currently lacking. Mesenchymal stromal/stem cell-derived exosomes (MSC-Exos) have regenerative properties that can repair cartilage damage, lower...

Full description

Saved in:
Bibliographic Details
Main Authors: Siyi Xie, Meiling Liu, Yajie Kong, Yiming Yang, Ruixue Chen, Yuzhong Wang, Shuxing Cao, Yongzhou Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2025.1549096/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850063225135038464
author Siyi Xie
Siyi Xie
Meiling Liu
Meiling Liu
Yajie Kong
Yajie Kong
Yiming Yang
Ruixue Chen
Yuzhong Wang
Shuxing Cao
Yongzhou Song
Yongzhou Song
Yongzhou Song
author_facet Siyi Xie
Siyi Xie
Meiling Liu
Meiling Liu
Yajie Kong
Yajie Kong
Yiming Yang
Ruixue Chen
Yuzhong Wang
Shuxing Cao
Yongzhou Song
Yongzhou Song
Yongzhou Song
author_sort Siyi Xie
collection DOAJ
description Osteoarthritis (OA) and type 2 diabetes mellitus (T2DM) often coexist due to shared risk factors and high prevalence, but effective treatment methods are currently lacking. Mesenchymal stromal/stem cell-derived exosomes (MSC-Exos) have regenerative properties that can repair cartilage damage, lower blood sugar levels, and improve pancreatic β cell function, showing great potential in tissue repair. This review primarily explores the application of MSC-Exos in the treatment of OA and T2DM, the potential mechanisms of MSC-Exos, and the therapeutic strategies of engineered exosomes. Although MSC-Exo therapy shows promising therapeutic potential, further research is needed to validate its safety and feasibility.
format Article
id doaj-art-28d9b2a38bc54fbca86af73b0208ff4c
institution DOAJ
issn 2296-634X
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj-art-28d9b2a38bc54fbca86af73b0208ff4c2025-08-20T02:49:43ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2025-03-011310.3389/fcell.2025.15490961549096Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitusSiyi Xie0Siyi Xie1Meiling Liu2Meiling Liu3Yajie Kong4Yajie Kong5Yiming Yang6Ruixue Chen7Yuzhong Wang8Shuxing Cao9Yongzhou Song10Yongzhou Song11Yongzhou Song12Department of Orthopedics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaHebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei, ChinaDepartment of Orthopedics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaHebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei, ChinaDepartment of Orthopedics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaHebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei, ChinaHebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei, ChinaHebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei, ChinaDepartment of Orthopedics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaDepartment of Orthopedics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaDepartment of Orthopedics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaHebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei, ChinaHebei Key Laboratory of Rare Disease, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaOsteoarthritis (OA) and type 2 diabetes mellitus (T2DM) often coexist due to shared risk factors and high prevalence, but effective treatment methods are currently lacking. Mesenchymal stromal/stem cell-derived exosomes (MSC-Exos) have regenerative properties that can repair cartilage damage, lower blood sugar levels, and improve pancreatic β cell function, showing great potential in tissue repair. This review primarily explores the application of MSC-Exos in the treatment of OA and T2DM, the potential mechanisms of MSC-Exos, and the therapeutic strategies of engineered exosomes. Although MSC-Exo therapy shows promising therapeutic potential, further research is needed to validate its safety and feasibility.https://www.frontiersin.org/articles/10.3389/fcell.2025.1549096/fullosteoarthritistype 2 diabetes mellitusdiabetic osteoarthritismesenchymal stromal/stem cell-derived exosomesmicroRNAsengineered exosomes
spellingShingle Siyi Xie
Siyi Xie
Meiling Liu
Meiling Liu
Yajie Kong
Yajie Kong
Yiming Yang
Ruixue Chen
Yuzhong Wang
Shuxing Cao
Yongzhou Song
Yongzhou Song
Yongzhou Song
Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
Frontiers in Cell and Developmental Biology
osteoarthritis
type 2 diabetes mellitus
diabetic osteoarthritis
mesenchymal stromal/stem cell-derived exosomes
microRNAs
engineered exosomes
title Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
title_full Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
title_fullStr Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
title_full_unstemmed Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
title_short Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
title_sort mesenchymal stromal stem cell derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
topic osteoarthritis
type 2 diabetes mellitus
diabetic osteoarthritis
mesenchymal stromal/stem cell-derived exosomes
microRNAs
engineered exosomes
url https://www.frontiersin.org/articles/10.3389/fcell.2025.1549096/full
work_keys_str_mv AT siyixie mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT siyixie mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT meilingliu mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT meilingliu mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT yajiekong mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT yajiekong mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT yimingyang mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT ruixuechen mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT yuzhongwang mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT shuxingcao mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT yongzhousong mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT yongzhousong mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus
AT yongzhousong mesenchymalstromalstemcellderivedexosomesasapotentialtherapeuticapproachtoosteoarthritiscombinedwithtype2diabetesmellitus